Evidence map›Paper›PMID 33008087›Full record

ArticlePharmaceuticals (Basel, Switzerland)2020

Resveratrol Metabolites Are Able to Reduce Steatosis in Cultured Hepatocytes.

Jenifer Trepiana, Stéphanie Krisa, Elodie Renouf, María Puy Portillo

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Anti-Steatotic Effect ofInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Anti-Steatotic Effects ofNutrients · 2023
    Article
  9. Article
  10. Article
  11. Review
  12. Heat-KilledFoods (Basel, Switzerland) · 2022
    Article
  13. Nutrients · 2021
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Jenifer TrepianaNutrition and Obesity Group, Department of Nutrition and Food Science, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), and Lucio Lascaray Research Centre, 01006 Vitoria-Gasteiz, Spain.ORCID 0000-0003-1316-5923
Stéphanie KrisaUniversité de Bordeaux, UR Œnologie, MIB, EA 4577, USC 1366 INRA, 33882 Villenave d'Ornon, France.
Elodie RenoufUniversité de Bordeaux, UR Œnologie, MIB, EA 4577, USC 1366 INRA, 33882 Villenave d'Ornon, France.
María Puy PortilloNutrition and Obesity Group, Department of Nutrition and Food Science, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), and Lucio Lascaray Research Centre, 01006 Vitoria-Gasteiz, Spain.ORCID 0000-0003-0210-6549
Université de Bordeaux · FRUniversity of the Basque Country · ES

Funding

Euskal Herriko Unibertsitatea GIU 18/173Instituto de Salud Carlos III CB12/03/30007Ministerio de Economía, Industria y Competitividad, Gobierno de España AGL-2015-65719-R
6 · The paper itself

Abstract

Steatosis is characterized primarily by excessive lipid accumulation in the form of triglycerides in the liver. Although resveratrol shows a low bioavailability, it has significant positive effects on steatosis. The aim of this study was to analyze whether some phase II and microbial resveratrol metabolites (

Indexed as

AML12 hepatocytesdihydroresveratrolliver steatosisresveratrol metabolitestrans-resveratrol-3-O-glucuronidetrans-resveratrol-3-O-sulfatetrans-resveratrol-4′-O-glucuronide

Identifiers

PMID33008087
PMCPMC7601480
OpenAlexW3091092004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.